{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:15:57Z","timestamp":1773112557530,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005491.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000}}],"reference-count":63,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005491.pub3","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T10:41:04Z","timestamp":1464086464000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Corticosteroids for treating nerve damage in leprosy"],"prefix":"10.1002","volume":"2017","author":[{"given":"Natasja HJ","family":"Van Veen","sequence":"first","affiliation":[{"name":"Erasmus Medical Center; Department of Public Health; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G","family":"Nicholls","sequence":"additional","affiliation":[{"name":"University of Southampton; School of Health Sciences; University Road Highfield Southampton UK SO17 1BJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W Cairns S","family":"Smith","sequence":"additional","affiliation":[{"name":"University of Aberdeen; Public Health; Polwarth Building Foresterhill Aberdeen UK AB25 2ZD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Hendrik","family":"Richardus","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center; Department of Public Health; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1590\/S0004-282X2008000600016","article-title":"A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions","volume":"66","author":"Garbino","year":"2008","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.47276\/lr.77.1.25","article-title":"Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy","volume":"77","author":"Sundar Rao","year":"2006","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.47276\/lr.74.4.311","article-title":"Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3)","volume":"74","author":"Richardus","year":"2003","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.47276\/lr.74.4.300","article-title":"The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2)","volume":"74","author":"Brakel","year":"2003","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e1041","DOI":"10.1371\/journal.pntd.0001041","article-title":"A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and\/or nerve function impairment","volume":"5","author":"Walker","year":"2011","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0006|cit6","first-page":"171","article-title":"Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis","volume":"11","author":"Boucher","year":"1999","journal-title":"Acta Leprologica"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5935\/0305-7518.20000018","article-title":"The treatment of acute nerve function impairment in leprosy: results from a prospective cohort study in Bangladesh","volume":"71","author":"Croft","year":"2000","journal-title":"Leprosy Review"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5935\/0305-7518.19910004","article-title":"Treatment of leprous neuritis by neurolysis combined with perineural corticosteroid injection","volume":"62","author":"Dandapat","year":"1991","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD005491.pub3-BIB0009|cit9","first-page":"282","article-title":"Comparative trial of steroids and surgical intervention in the management of ulnar neuritis","volume":"64","author":"Ebenezer","year":"1996","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"4A","key":"10.1002\/14651858.CD005491.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1590\/S0004-282X2007000600009","article-title":"Pure neural leprosy: steroids prevent neuropathy progression","volume":"65","author":"Jardim","year":"2007","journal-title":"Arquivos de Neuropsiquiatria"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0011|cit11","unstructured":"Lambert SM Lockwood DN A randomised double blind controlled trial comparing ciclosporin and prednisolone in the treatment of new leprosy type 1 reactions Email to DN Lockwood, London School of Hygiene & Tropical Medicine (sent on 4 August 2014)"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0012|cit12","unstructured":"Lockwood DN Azathioprine in the treatment of leprosy reactions Email to DN Lockwood, London School of Hygiene & Tropical Medicine (sent on 4 August 2014)"},{"issue":"10","key":"10.1002\/14651858.CD005491.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.trstmh.2003.12.013","article-title":"Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal","volume":"98","author":"Marlowe","year":"2004","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"10","key":"10.1002\/14651858.CD005491.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.trstmh.2006.11.010","article-title":"Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions","volume":"101","author":"Marlowe","year":"2007","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0015|cit15","first-page":"501","article-title":"Effect of epicondylectomy in early ulnar neuritis treated with steroids","volume":"52","author":"Pannikar","year":"1984","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"7454","key":"10.1002\/14651858.CD005491.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.38107.645926.AE","article-title":"Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1)","volume":"328","author":"Smith","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0017|cit17","first-page":"20","article-title":"Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis","volume":"65","author":"Wilder-Smith","year":"1997","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005491.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5935\/0305-7518.19990034","article-title":"Reliability of Semmes Weinstein monofilament and ballpoint sensory testing, and voluntary muscle testing in Bangladesh","volume":"70","author":"Anderson","year":"1999","journal-title":"Leprosy Review"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/0305-7518.19900001","article-title":"The management of nerve damage in the leprosy control services","volume":"61","author":"Becx-Bleumink","year":"1990","journal-title":"Leprosy Review"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0894-1130(12)80366-8","article-title":"\"Pocket filaments\" and specifications for the Semmes-Weinstein monofilaments","volume":"3","author":"Bell-Krotoski","year":"1990","journal-title":"Journal of Hand Therapy"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5935\/0305-7518.19810019","article-title":"Basic nerve function assessment in leprosy patients","volume":"52","author":"Brandsma","year":"1981","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD005491.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5935\/0305-7518.19980024","article-title":"The management of leprosy reversal reactions","volume":"69","author":"Britton","year":"1998","journal-title":"Leprosy Review"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5935\/0305-7518.19990018","article-title":"Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study)","volume":"70","author":"Croft","year":"1999","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1489\/1544-581X(2004)72<437:TDOSIL>2.0.CO;2","article-title":"The dynamics of stigma in leprosy","volume":"72","author":"Heijnders","year":"2004","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0026|cit26","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0027|cit27","volume-title":"How to Diagnose and Treat Leprosy","author":"The International Federation of Anti-Leprosy Associations (ILEP)","year":"2001"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0028|cit28","volume-title":"How to Recognise and Manage Reactions","author":"The International Federation of Anti-Leprosy Associations (ILEP)","year":"2002"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0029|cit29","first-page":"532","article-title":"Nerve damage in leprosy","volume":"57","author":"Job","year":"1989","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.47276\/lr.74.1.42","article-title":"Sensory testing in leprosy: comparison of ballpoint pen and monofilaments","volume":"74","author":"Koelewijn","year":"2003","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.47276\/lr.75.4.367","article-title":"Prevalence of mental distress in the outpatient clinic of a specialized leprosy hospital. Addis Ababa, Ethiopia, 2002","volume":"75","author":"Leekassa","year":"2004","journal-title":"Leprosy Review"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5935\/0305-7518.19940002","article-title":"Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?","volume":"65","author":"Lienhardt","year":"1994","journal-title":"Leprosy Review"},{"issue":"5","key":"10.1002\/14651858.CD005491.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/IAI.69.5.3413-3417.2001","article-title":"Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment","volume":"69","author":"Little","year":"2001","journal-title":"Infection and Immunity"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0034|cit34","first-page":"8","article-title":"Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India","volume":"61","author":"Lockwood","year":"1993","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"Supplement","key":"10.1002\/14651858.CD005491.pub3-BIB0035|cit35","first-page":"S111","article-title":"Steroids in leprosy type 1 (reversal) reactions: mechanisms of action and effectiveness","volume":"71","author":"Lockwood","year":"2000","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD005491.pub3-BIB0036|cit36","first-page":"230","article-title":"Leprosy: too complex a disease for a simple elimination paradigm","volume":"83","author":"Lockwood","year":"2005","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0037|cit37","first-page":"7","article-title":"Reversal reaction: the prevention of permanent nerve damage. Comparison of short and long-term steroid treatment","volume":"47","author":"Naafs","year":"1979","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"4 Supplement","key":"10.1002\/14651858.CD005491.pub3-BIB0038|cit38","first-page":"S21","article-title":"Treatment of reactions and nerve damage","volume":"64","author":"Naafs","year":"1996","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.47276\/lr.74.4.328","article-title":"Treatment duration of reversal reaction: a reappraisal. Back to the past","volume":"74","author":"Naafs","year":"2003","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.47276\/lr.74.4.349","article-title":"Delay in presentation, an indicator for nerve function status at registration and for treatment outcome - the experience of the Bangladesh Acute Nerve Damage Study cohort","volume":"74","author":"Nicholls","year":"2003","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5935\/0305-7518.19810039","article-title":"The use of corticosteroids in leprosy","volume":"52","author":"Pearson","year":"1981","journal-title":"Leprosy Review"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5935\/0305-7518.19820015","article-title":"The evaluation of nerve damage in leprosy","volume":"53","author":"Pearson","year":"1982","journal-title":"Leprosy Review"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.47276\/lr.76.2.119","article-title":"Curing the stigma of leprosy","volume":"76","author":"Rafferty","year":"2005","journal-title":"Leprosy Review"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0044|cit44","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.47276\/lr.74.4.319","article-title":"Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials","volume":"74","author":"Richardus","year":"2003","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD005491.pub3-BIB0046|cit46","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5935\/0305-7518.19910013","article-title":"Reversal reactions in leprosy and their management","volume":"62","author":"Rose","year":"1991","journal-title":"Leprosy Review"},{"issue":"9","key":"10.1002\/14651858.CD005491.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/09638280600926587","article-title":"The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes","volume":"29","author":"SALSA Collaborative Study Group","year":"2007","journal-title":"Disability and Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD005491.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5935\/0305-7518.20000033","article-title":"The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome","volume":"71","author":"Saunderson","year":"2000","journal-title":"Leprosy Review"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0050|cit50","first-page":"170","article-title":"The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments","volume":"66","author":"Schreuder","year":"1998","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0051|cit51","first-page":"10","article-title":"Leprosy reactions - complications of steroid therapy","volume":"66","author":"Sugumaran","year":"1998","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5935\/0305-7518.19960011","article-title":"Nerve function impairment in leprosy: an epidemiological and clinical study - Part 2: Results of steroid treatment","volume":"67","author":"Brakel","year":"1996","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD005491.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.47276\/lr.76.1.14","article-title":"The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India","volume":"76","author":"Brakel","year":"2005","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/09638280500192785","article-title":"The Participation Scale: measuring a key concept in public health","volume":"28","author":"Brakel","year":"2006","journal-title":"Disability and Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006983.pub2","article-title":"Decompressive surgery for treating nerve damage in leprosy","author":"Veen","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005491.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2012.10891.x","article-title":"The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy Type 1 reactions","volume":"167","author":"Walker","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0057|cit57","unstructured":"World Health Organization WHO Action Programme for the Elimination of Leprosy. A guide to eliminate leprosy as a public health problem World Health Organization 1995"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0058|cit58","first-page":"1","article-title":"WHO Expert Committee on Leprosy [editorial]","volume":"874","author":"World Health Organization","year":"1998","journal-title":"World Health Organization Technical Report Series"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0059|cit59","unstructured":"World Health Organization WHO Leprosy Elimination Project: Status Report 2003 Geneva: World Health Organization"},{"key":"10.1002\/14651858.CD005491.pub3-BIB0060|cit60","unstructured":"World Health Organization Leprosy http:\/\/www.who.int\/mediacentre\/factsheets\/fs101\/en\/index.html"},{"issue":"35","key":"10.1002\/14651858.CD005491.pub3-BIB0061|cit61","first-page":"365","article-title":"Global leprosy: update on the 2012 situation","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Weekly Epidemiological Record"},{"issue":"4","key":"10.1002\/14651858.CD005491.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005491","article-title":"Corticosteroid interventions for treating nerve damage in leprosy","author":"Veen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005491.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005491.pub2","article-title":"Corticosteroids for treating nerve damage in leprosy","author":"Veen","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005491.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:03:43Z","timestamp":1704355423000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005491.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005491.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}